Anza Therapeutics
Concord
About Anza Therapeutics
Anza Therapeutics is a biotechnology company that develops immunotherapies for infectious diseases and cancer. The company's agents are based on its proprietary live-attenuated and Killed But Metabolically Active (KBMA) Listeria platforms which can be engineered to express antigens specific to the disease.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Last round: Series Unknown (Jan 2007)
- Website: anzatherapeutics.com
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/anza-therapeutics-2260410 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.